CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02642640
NCT02642640N/ACompleted
CompareCT.gov

Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1

Brigham and Women's Hospital·interventional·Posted Dec 30, 2015·Updated Feb 12, 2026

In Brief

A clinical study evaluating melatonin and placebo for Glucose and 3 related conditions. Completed, enrolled 23 participants across 1 site.

Detailed Summary

This project aims to test the impact of melatonin and MTNR1B variation on regulation glucose regulation in a highly controlled in-laboratory setting and ex vivo in pancreatic islets.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlucose, Circadian Rhythm, Melatonin, Genes
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 30, 2015
Enrollment StartNov 1, 2016
Primary CompletionMar 24, 2022
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 10.5 years ago

Interventions

melatonindietary

5 mg of melatonin per os.

placebodrug